Ehrly A M, Landgraf H
Fortschr Med. 1982 May 27;100(20):969-71.
Pervincamine has been launched since several years for the therapy of cardiovascular disease. As the mechanism of efficacy is not known very well it has been investigated whether the substance has a favorable influence on the rheology of the blood in in vitro studies. The addition of different concentrations of Pervincamin to normoosmolar blood samples showed no change of the rheology of blood in vitro. Under hyperosmolar loading conditions as they can be found comparatively in the blood of the microcirculation of an ischemic working muscle, a statistically significant improvement of the filtration of erythrocytes can be found which is largely due to an improvement of the flexibility of the erythrocyte. These investigations show that Pervincamin effects favorably rheological properties under certain conditions. Further analyses are necessary in order to elucidate the relation between cerebrovascular insufficiency on one hand and the vincamin induced improvement of rheology on the other.
长春胺已经上市数年,用于治疗心血管疾病。由于其疗效机制尚不完全清楚,因此在体外研究中对该物质是否对血液流变学有有利影响进行了研究。向等渗血液样本中添加不同浓度的长春胺,体外血液流变学未发生变化。在高渗负荷条件下,如在缺血工作肌肉微循环血液中相对常见的情况,可发现红细胞滤过有统计学意义的改善,这主要归因于红细胞柔韧性的改善。这些研究表明,长春胺在某些条件下对血液流变学特性有有利影响。为了阐明一方面的脑血管供血不足与另一方面长春胺诱导的血液流变学改善之间的关系,还需要进一步分析。